Consequently, ABCA1 down-regulation during AD would disrupt BBB integrity, generate pro-inflammatory signaling and decrease ApoE lipidation with subsequent Aβ aggregation and less trafficking into the perivascular spaces to be eliminated by LRP1. Here, ABCA1 is linked to Alzheimer disease.